micro-community-banner
 
  • Saved
Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey - PubMed

Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/37386469/

Our findings demonstrated the high burden of MG despite current treatment options for patients with MG.

Conclusions: Our findings demonstrated the high burden of MG despite current treatment options for patients with MG.

  • Saved
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis - Neurology and Therapy

Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis - Neurology and Therapy

Source : https://link.springer.com/article/10.1007/s40120-023-00514-4

This article provides a summary of a previously published paper: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis. The paper reported the results of the CHAMPION-MG trial which investigated the...

Conclusions/Relevance: Ravulizumab improved symptoms and muscle strength compared with placebo in patients with gMG who had acetylcholine receptor antibodies, and its side effects were mild in most patients.
 

  • Saved
Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology - Acta Neuropathologica

Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology - Acta Neuropathologica

Source : https://link.springer.com/article/10.1007/s00401-023-02603-y

Serum autoantibodies targeting the nicotinic acetylcholine receptor (AChR) in patients with autoimmune myasthenia gravis (MG) can mediate pathology via three distinct molecular mechanisms: complement activation, receptor blockade, and antigenic modulation....

Conclusions/Relevance: These findings provide new insight into the immunopathology of MG, demonstrating that single autoreactive clones can efficiently mediate multiple modes of pathology. Current therapeutic approaches targeting only one autoantibody-mediated pathogenic mechanism may be evaded by autoantibodies with multifaceted capacity.

  • Saved
Myasthenia-like paraneoplastic syndrome with multiple... : Medicine

Myasthenia-like paraneoplastic syndrome with multiple... : Medicine

Source : https://journals.lww.com/md-journal/Fulltext/2023/05190/Myasthenia_like_paraneoplastic_syndrome_with.52.aspx

ation with primary lung cancer remains unknown. Patient concerns: A 55-year-old female presented with slurred speech, weakness in chewing, sporadic difficulty in swallowing, and weakness in both lower limbs for...

Lessons: Although it is unclear why MG coexists with lung cancer, it is probable that MG is a paraneoplastic condition. Cerebrospinal fluid testing should be carried out along with electrophysiological, serological, and pharmacological procedures pertinent to the diagnosis of MG to thoroughly examine if people simultaneously experience...

  • Saved
Myasthenic crisis as an initial presentation of myasthenia gravis in an 81-year-old following endoscopic myotomy for Zenker's diverticulum

Myasthenic crisis as an initial presentation of myasthenia gravis in an 81-year-old following endoscopic myotomy for Zenker's diverticulum

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269386/

In this article, we present the case of a patient with previously undiagnosed myasthenia gravis who underwent an endoscopic procedure for Zenker's diverticulum. The patient was readmitted due to ongoing...

Conclusions/Relevance: This case demonstrates that myasthenia gravis, although rare, can occur in elderly patients and present with other sequelae that may mask the underlying diagnosis.